Nanoparticle delivery of molecular agents to tackle HIV latency

AAJ Ali - 2022 - bonndoc.ulb.uni-bonn.de
Antiretroviral therapy (ART) effectively suppresses HIV replication in people living with HIV
(PLWH), but treatment is lifelong. The persistence of long-lived, latently infected resting …

[PDF][PDF] HPLC-Based Purification and Isolation of Potent Anti-HIV and Latency Reversing Daphnane Diterpenes from the Medicinal Plant Gnidia sericocephala …

B Tembeni, A Sciorillo, L Invernizzi, T Klimkait, L Urda… - 2022 - researchgate.net
Despite the success of combination antiretroviral therapy (cART), HIV persists in low-and
middle-income countries (LMIC) due to emerging drug resistance and insufficient drug …

Documentation and molecular analysis of African medicinal plants and naturally-produced chemical compounds that modulate latent HIV-1 infection

K Richard - 2022 - summit.sfu.ca
HIV cure continues to be elusive due to cellular reservoirs that persist despite the highly
potent combined antiretroviral therapy (cART) which suppresses HIV plasma viremia to …

[PDF][PDF] https://www. jbc. org/cgi/doi/10.1074/jbc. RA120. 013031 The latest version is at

K Richard, C Schonhofer, LB Giron, J Rivera-Ortiz… - researchgate.net
ABSTRACT A sterilizing or functional cure for HIV is currently precluded by resting CD4+ T
cells that harbor latent but replication-competent provirus. The “shock-and-kill” …

[PDF][PDF] M. Tuberculosis and HIV-Prolific Killers in Developing Countries are Syndemic Pathogens

MV Hosur - tbinfo.org
According to a World Health Organisation (WHO) report, non-communicable diseases
accounted for 74% of deaths globally in 2019 [1]. Major contributors to this class are …